Investigational HIV therapeutic vaccine approach helps control SIV in preclinical studies

(The U.S. Military HIV Research Program (MHRP)) An investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy in non-human primates infected with SIV.

Source: EurekAlert! - Medicine and Health - November 9, 2016 Category: Global & Universal Source Type: news